# Symptoms and phases of severe beta thalassemia
Severe beta thalassemia (transfusion-dependent form) is a condition where the body does not produce enough normal hemoglobin. This leads to severe anemia and many consequences for organs and daily life. The course varies from person to person, depending on genetic factors, the quality of treatment and individual susceptibility to complications.
Infant period and early childhood (diagnosis up to approximately 6 months)
In the first months of life, symptoms are often not yet clear. Newborns still have a lot of fetal hemoglobin (HbF), which partly compensates for their anemia. But gradually, as this hemoglobin decreases, signs of anemia become visible.
**Complaints and signs: **
- **Pale skin and pale mucosa** — the child looks very pale
- **Jaundice** (yellowing of the skin and eyes) — due to the breakdown of red blood cells
- **Slowdown in growth and development** — the child is gaining weight less rapidly
- **Large sple** (splenomegaly) — felt as a swelling under the ribs on the left
- **Large liver** (hepatomegaly) — felt as swelling under the right ribs
- **Very fast heart rhythm** and possible heart rhythm disorders
- **Shortness of breath** when exercising or at rest
- **Irritability and fatigue**
**What this means for daily life: **
Parents notice that the child has less energy than peers, gets tired faster and is silent more often. The pale appearance can stand out and can be psychologically taxing. Regular hospital visits for blood transfusions are necessary — this determines much of the daily routine.
**Figures about this phase: **
Most children are diagnosed between 3 and 6 months of age. Blood levels are very low: haemoglobin levels usually fall below 7 g/dL without treatment. With regular transfusions, these values can be monitored. This phase is crucial: early, well-administered transfusion therapy helps determine how well the child feels in later years.
Early childhood to puberty (6 months to approximately 12 years)
This is the period when the child grows, goes to school and has to fit into a group — while transfusions and complications become increasingly present.
**Complaints and signs: **
- **Continued anemia symptoms** — tiredness, paleness, trouble concentrating at school
- **Slowed growth** — the child is significantly smaller than peers; growth disruption occurs due to severe anemia, iron overload and hormone problems
- **Bone reinforcement** in the face and skull — bone enlargement due to bone marrow overwork; eye sockets increase, cheekbones stronger, face gets a characteristic appearance
- **Teeth defects** — teeth grow crooked, gaps widen
- **Back pain and stiffness** — osteoporosis begins; the bone becomes brittle and sore
- **Heart rhythm disorders** — including iron overload
- **Liver problems** — hepatitis C or iron cirrhosis may develop
- **Renal dysfunctions** — first signs of kidney disease
- **Cognitive effects** — some children have concentration and learning problems (2026 studies indicate possible cognitive consequences in this phase)
- **Psychosocial challenges** — the child feels different from peers, school absenteeism due to hospital visits
**What this means for daily life: **
School is becoming more difficult, both because of concentration problems and frequent absenteeism for transfusions (usually every 2-4 weeks for 4-6 hours). The child cannot simply participate in sports or play activities; exercise causes shortness of breath. Friendships are difficult because the child spends time or feels different elsewhere. Parents are increasingly concerned about complications. Regular examinations (ultrasounds, blood tests) have become routine.
**Figures about this phase: **
Without adequate treatment, many children in this phase experience severe growth disturbances. With modern transfusion therapy (where hemoglobin target values are regularly maintained) and iron removal, growth progresses better. Most studies show that well-treated children remain in school, though with limitations. Survival to adulthood was rare decades ago; nowadays, well-treated children reach their twenties to thirties on average and beyond. Exact figures depend heavily on country, treatment quality, and genetic factors. Recent research (2026) points to growing attention for bone health and cognitive consequences in this period.
Adolescence to young adulthood (12-25 years)
This is a critical transition period in which the body matures, but complications become increasingly apparent.
**Complaints and signs: **
- **Persistent anemia symptoms** — now a permanent part of life, but sometimes worse in this phase due to growth process and hormonal changes
- **Delayed puberty** — many teenagers experience puberty much later than their peers or not at all; this is psychologically very burdensome
- **Infertility or sexual dysfunction** — hormone deficiencies and organ damage cause infertility in both boys and girls; erectile dysfunction in boys can occur
- **Osteoporosis with bone fractures** — bones break more easily; back and pelvic pain increase; some patients experience pathological fractures (breaks without clear cause)
- **Heart problems** — iron deficiency in heart muscle (iron cardiomyopathy) causes arrhythmias, heart failure, and sometimes sudden cardiac arrest
- **Lung problems** — elevated blood pressure in the lungs (pulmonary hypertension) becomes increasingly likely; this causes shortness of breath and fatigue
- **Liver cirrhosis** — the liver becomes filled with scar tissue; liver insufficiency threatens
- **Declining kidney function** — albumin loss in urine, increase in creatinine
- **Endocrine disorders** — diabetes, thyroid conditions, adrenal damage
- **Psychological burden** — anxiety about the future, depression, isolation
**What this means for daily life: **
Many teenagers feel increasingly different and excluded. Romantic relationships and sexuality become more complicated by body changes, infertility problems, and fatigue. Studying becomes harder; choosing university is difficult due to frequent medical appointments and physical limitations. Job searching is problematic; employers hesitate. Independence from parents is harder to achieve. Many young people struggle with accepting their situation. Hospital visits remain frequent (usually monthly or more often). Iron removal procedures (infusions, usually subcutaneous or intravenous several times per week) take up much time.
**Figures about this phase: **
Median survival in well-equipped centers is around 40-50 years (based on studies through 2020-2022), but this is an average across large groups. Individual differences are enormous. Some patients reach 60 years; others die in their twenties or thirties, depending on heart complications, infections, or other factors. Research from 2026 increasingly focuses on quality of life in this phase — not just on survival. Pulmonary hypertension is recognized in increasingly more studies as an important risk factor for earlier death.
Middle and mature adulthood (25-40+ years)
For those who reach this age, thalassemia is a fully integrated, but highly burdensome chronic condition.
**Complaints and signs: **
- **Severe fatigue** — not only due to anemia, but also due to years of disease burden
- **Heart failure** — many patients have reduced pumping strength of the heart; fluid accumulation, shortness of breath, ankle swelling
- **Arrhythmias** — irregular heartbeats, potentially life-threatening
- **Lung diseases** — pulmonary hypertension, respiratory insufficiency
- **Liver cirrhosis with possible liver failure** — jaundice, fluid in abdomen (ascites), hepatic encephalopathy (confusion due to liver insufficiency)
- **Severe osteoporosis with multiple bone fractures** — some are in wheelchairs due to fractures
- **Kidney disease** — decline in kidney function, possible kidney failure
- **Blood clots** (thrombosis) — extra risk of pulmonary embolism and stroke
- **Endocrine failure** — diabetes fully developed, thyroid function completely gone, hormone replacement therapy needed
- **Infections** — immune system is weakened and non-functioning spleen increases infection risk
- **Cancer risk** — slightly increased risk of certain cancers, possibly related to iron overload and chronic inflammation
- **Cognitive decline** — some have memory or concentration problems
- **Sexual dysfunction** — very common at this age
- **Psychiatric comorbidity** — depression, anxiety disorders, burnout from decades-long disease burden
**What this means for daily life: **
Many adults can no longer work; disability is often necessary. Relationships are severely strained by infertility, sexual problems, and psychological burden. Many patients are socially isolated. Daily life is completely focused on medical treatment: transfusions, iron removal procedures, countless medications, hospital visits. Pain (bones, heart, muscles) is chronically present. Many patients feel old for their age. Quality of life decreases significantly; many struggle with suicidal thoughts or engage in risky behavior. Caregivers (parents, partners, professionals) become exhausted.
**Figures about this phase: **
Most studies from before 2020 spoke of median survival around 40 years in countries with good care. Recent trends (2020-2026) show better outcomes, possibly due to better cardiac screening, better iron removal and better physician knowledge of complications — but mortality rates are still significant. Some patients reach their 50s or 60s, but this is not the rule. A considerable number die in their 30s or 40s, especially from cardiac complications. Studies from 2026 point to growing muscle loss (sarcopenia) and bone disorders as undervalued factors in this phase. Gene-editing studies (CRISPR approaches in trials since 2025-2026) may help future generations better, but have not yet impacted the current adult patient population.
When to contact your healthcare provider
Regardless of age and phase, contact should be made immediately (outpatient clinic or emergency room) if:
- **Severe shortness of breath or chest pain** — may indicate heart attack or pulmonary embolism
- **Severe dizziness, fainting, irregular heartbeat** —